Robert RISINGER
8Patents
1h-index
5Co-inventors
33Inventor score
Filing activity: Nov 23, 2022 → Mar 8, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11806334B1 | Non-sedating dexmedetomidine treatment regimens | Human Necessities | 3 | Active |
| US11890272B2 | Non-sedating dexmedetomidine treatment regimens | Human Necessities | 1 | Active |
| US12090140B2 | Non-sedating dexmedetomidine treatment regimens | Human Necessities | 0 | Active |
| US11998528B1 | Non-sedating dexmedetomidine treatment regimens | Human Necessities | 0 | Active |
| US12109196B2 | Non-sedating dexmedetomidine treatment regimens | Human Necessities | 0 | Active |
| US11998529B2 | Non-sedating dexmedetomidine treatment regimens | Human Necessities | 0 | Active |
| US12364683B2 | Non-sedating dexmedetomidine treatment regimens | Human Necessities | 0 | Active |
| US12138247B2 | Non-sedating dexmedetomidine treatment regimens | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.